FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to a composition for producing a microneedle, a soluble microneedle and a transcutaneous patch with microneedles comprising a soluble microneedle. Composition for producing the microneedle contains donepezil or a pharmaceutically acceptable salt thereof and hyaluronic acid or a pharmaceutically acceptable salt thereof, where the weight ratio of donepezil or its pharmaceutically acceptable salt and hyaluronic acid or its pharmaceutically acceptable salt ranges from 1:1.5 to 1:2.9.
EFFECT: technical result is obtaining a soluble microneedle contained in a transcutaneous patch with microneedles, having high capacity of drug loading and excellent strength, thus containing an effective amount of donepezil or its pharmaceutically acceptable salt even with a small area of microneedle, wherein the transcutaneous patch provides a low level of skin irritation.
15 cl, 4 ex, 7 tbl, 8 dwg
Title | Year | Author | Number |
---|---|---|---|
TRANSDERMAL DRUG FOR TREATMENT OF DEMENTIA CONTAINING DONEPEZIL | 2018 |
|
RU2775315C2 |
TRANSDERMAL COMPOSITION CONTAINING DONEPEZIL AS ACTIVE INGREDIENT | 2015 |
|
RU2713207C2 |
TRANSDERMALLY ABSORBABLE FORMULATION CONTAINING DONEPEZIL | 2010 |
|
RU2545696C2 |
TRANSCUTANEOUS ABSORPTION PREPARATION CONTAINING STABILIZED DONEPEZIL | 2019 |
|
RU2814017C2 |
TRANSDERMAL DONEPEZIL DELIVERY SYSTEM | 2017 |
|
RU2779471C2 |
MICROSTRUCTURE FOR TRANSDERMAL ADMINISTRATION AND A METHOD FOR PRODUCTION THEREOF | 2016 |
|
RU2701361C1 |
METHOD OF ANTIDEMENTIA DRUG STABILISATION | 2005 |
|
RU2401125C2 |
METHOD FOR STAINING INHIBITION OF DONEPEZIL-CONTAINING ADHESIVE COMPOSITION AND METHOD FOR REDUCTION OF FORMED DONEPEZIL-RELATED COMPOUNDS | 2007 |
|
RU2460520C2 |
PERCUTANEOUS DELIVERY SYSTEM, USING MICROPOROUS MEMBRANE CONTAINING PORES FILLED WITH SOLVENT | 2018 |
|
RU2789194C2 |
COMPOSITION FOR TRANSCUTANEOUS ABSORPTION | 2007 |
|
RU2435570C2 |
Authors
Dates
2020-11-09—Published
2018-05-16—Filed